Perfil
Andrew King worked as a Senior Director of Discovery & Translational Biology at Ardelyx, Inc. He then served as the Chief Scientific Officer at Chinook Therapeutics, Inc. from 2021 to 2023.
Dr. King holds a doctorate degree from Michigan State University and an undergraduate degree from Murdoch University.
Antiguos cargos conocidos de Andrew King.
| Empresas | Cargo | Fin |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 09/08/2023 |
| ARDELYX, INC. | Corporate Officer/Principal | - |
Formación de Andrew King.
| Murdoch University | Undergraduate Degree |
| Michigan State University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARDELYX, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew King
